Literature DB >> 9072009

Association of coronary plaque rupture and atherosclerotic inflammation.

J J Boyle1.   

Abstract

Coronary plaque inflammation may promote plaque rupture and thrombosis. To test this hypothesis, 351 coronary plaques from 83 patients were formalin-fixed and stained with haematoxylin and eosin. There were six groups: (1) ruptured plaques; (2) intact plaques from recently infarcted hearts; (3) plaques from hearts with severe coronary atherosclerosis without identifiable thrombosis; (4) native explanted hearts with severe coronary atherosclerosis; (5) cardiac transplant atherosclerosis; and (6) fatalities unrelated to coronary atherosclerosis. Selected arteries were immunostained for leukocyte markers and serially sectioned to identify plaque rupture. There were infiltrates of CD68-positive macrophages and CD3- and CD8-positive T cells adjacent to all plaque ruptures. Labelling with HLA-DR and CD30 indicated inflammatory cell activation. Plaque rupture was strongly statistically associated with the severity and frequency of superficial plaque inflammation but not that of deep plaque inflammation. Although atherosclerotic inflammation has been identified adjacent to rupture, this is its first comparison with control plaques. These results support the concept that inflammation in the fibrous cap is particularly associated with plaque rupture.

Entities:  

Mesh:

Year:  1997        PMID: 9072009     DOI: 10.1002/(SICI)1096-9896(199701)181:1<93::AID-PATH696>3.0.CO;2-H

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  27 in total

1.  Comparison of classical and non-classical cardiovascular risk factors influencing the patency of native arteriovenous fistulas after percutaneous transluminal angioplasty therapy among haemodialysis patients.

Authors:  Jiung-Hsiun Liu; Po-Wen Lin; Yao-Lung Liu; Hsin-Hung Lin; Chiu-Ching Huang
Journal:  Postgrad Med J       Date:  2007-08       Impact factor: 2.401

Review 2.  Mast cells in atherogenesis: actions and reactions.

Authors:  Petri T Kovanen
Journal:  Curr Atheroscler Rep       Date:  2009-05       Impact factor: 5.113

Review 3.  Vaccination to modulate atherosclerosis.

Authors:  Takayuki Kimura; Kevin Tse; Alessandro Sette; Klaus Ley
Journal:  Autoimmunity       Date:  2015-02-16       Impact factor: 2.815

4.  Quantifying effects of plaque structure and material properties on stress distributions in human atherosclerotic plaques using 3D FSI models.

Authors:  Dalin Tang; Chun Yang; Jie Zheng; Pamela K Woodard; Jeffrey E Saffitz; Gregorio A Sicard; Thomas K Pilgram; Chun Yuan
Journal:  J Biomech Eng       Date:  2005-12       Impact factor: 2.097

Review 5.  MR plaque imaging of the carotid artery.

Authors:  Yuji Watanabe; Masako Nagayama
Journal:  Neuroradiology       Date:  2010-02-13       Impact factor: 2.804

Review 6.  Recent advances in ischaemic heart disease.

Authors:  M Cusack; S Redwood; J Coltart
Journal:  Postgrad Med J       Date:  2000-09       Impact factor: 2.401

7.  Coronary intraplaque hemorrhage evokes a novel atheroprotective macrophage phenotype.

Authors:  Joseph J Boyle; Heather A Harrington; Emma Piper; Kay Elderfield; Jaroslav Stark; Robert C Landis; Dorian O Haskard
Journal:  Am J Pathol       Date:  2009-03       Impact factor: 4.307

Review 8.  [New non-steroidal anti-rheumatic drugs: selective inhibitors of inducible cyclooxygenase].

Authors:  D O Stichtenoth; H Zeidler; J C Frölich
Journal:  Med Klin (Munich)       Date:  1998-07-15

9.  A robust rabbit model of human atherosclerosis and atherothrombosis.

Authors:  Alkystis Phinikaridou; Kevin J Hallock; Ye Qiao; James A Hamilton
Journal:  J Lipid Res       Date:  2009-01-12       Impact factor: 5.922

10.  3D MRI-based anisotropic FSI models with cyclic bending for human coronary atherosclerotic plaque mechanical analysis.

Authors:  Dalin Tang; Chun Yang; Shunichi Kobayashi; Jie Zheng; Pamela K Woodard; Zhongzhao Teng; Kristen Billiar; Richard Bach; David N Ku
Journal:  J Biomech Eng       Date:  2009-06       Impact factor: 2.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.